2021 Q2 Form 10-Q Financial Statement
#000156459021026981 Filed on May 12, 2021
Income Statement
Concept | 2021 Q2 | 2020 Q1 |
---|---|---|
Revenue | $11.96M | $9.021M |
YoY Change | 92.3% | -14.86% |
Cost Of Revenue | $7.020M | $5.105M |
YoY Change | 84.11% | -19.48% |
Gross Profit | $4.939M | $3.916M |
YoY Change | 105.28% | -8.08% |
Gross Profit Margin | 41.3% | 43.41% |
Selling, General & Admin | $5.620M | $4.850M |
YoY Change | 28.22% | -23.44% |
% of Gross Profit | 113.79% | 123.85% |
Research & Development | $1.170M | $719.0K |
YoY Change | 44.44% | -24.95% |
% of Gross Profit | 23.69% | 18.36% |
Depreciation & Amortization | $140.0K | $140.0K |
YoY Change | 0.0% | -33.33% |
% of Gross Profit | 2.83% | 3.58% |
Operating Expenses | $6.780M | $5.569M |
YoY Change | 54.69% | -23.64% |
Operating Profit | -$1.841M | -$1.653M |
YoY Change | -33.87% | -45.55% |
Interest Expense | ||
YoY Change | ||
% of Operating Profit | ||
Other Income/Expense, Net | -$161.0K | $9.000K |
YoY Change | -1888.89% | -250.0% |
Pretax Income | -$2.002M | -$1.644M |
YoY Change | -27.86% | -45.96% |
Income Tax | $8.000K | $7.000K |
% Of Pretax Income | ||
Net Earnings | -$2.010M | -$1.651M |
YoY Change | -27.7% | -45.83% |
Net Earnings / Revenue | -16.81% | -18.3% |
Basic Earnings Per Share | -$0.14 | -$0.12 |
Diluted Earnings Per Share | -$0.14 | -$119.7K |
COMMON SHARES | ||
Basic Shares Outstanding | 14.35M | 13.79M |
Diluted Shares Outstanding | 14.35M |
Balance Sheet
Concept | 2021 Q2 | 2020 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $27.99M | $11.14M |
YoY Change | 140.88% | -35.16% |
Cash & Equivalents | $29.02M | $11.14M |
Short-Term Investments | ||
Other Short-Term Assets | $1.000M | $690.0K |
YoY Change | 96.08% | -10.39% |
Inventory | $7.040M | $8.160M |
Prepaid Expenses | ||
Receivables | $8.190M | $6.990M |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $44.22M | $26.98M |
YoY Change | 71.66% | -23.05% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $1.950M | $3.170M |
YoY Change | -29.09% | -33.82% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $80.00K | $140.0K |
YoY Change | -50.0% | -26.32% |
Total Long-Term Assets | $5.340M | $3.920M |
YoY Change | 51.7% | -30.12% |
TOTAL ASSETS | ||
Total Short-Term Assets | $44.22M | $26.98M |
Total Long-Term Assets | $5.340M | $3.920M |
Total Assets | $49.56M | $30.90M |
YoY Change | 69.26% | -24.02% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $1.690M | $1.500M |
YoY Change | 201.79% | -37.5% |
Accrued Expenses | $4.790M | $4.950M |
YoY Change | 2.13% | -10.16% |
Deferred Revenue | $1.812M | $1.382M |
YoY Change | 48.28% | -20.67% |
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $2.185M | |
YoY Change | 96.85% | |
Total Short-Term Liabilities | $12.75M | $7.835M |
YoY Change | 68.17% | -18.81% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $310.0K | $0.00 |
YoY Change | -77.7% | |
Other Long-Term Liabilities | $22.00K | $19.00K |
YoY Change | -98.55% | -99.47% |
Total Long-Term Liabilities | $22.00K | $19.00K |
YoY Change | -99.24% | -99.47% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $12.75M | $7.835M |
Total Long-Term Liabilities | $22.00K | $19.00K |
Total Liabilities | $23.91M | $9.747M |
YoY Change | 128.15% | -26.27% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$58.95M | -$52.27M |
YoY Change | ||
Common Stock | $84.58M | $73.33M |
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $25.65M | $21.15M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $49.56M | $30.90M |
YoY Change | 69.26% | -24.03% |
Cashflow Statement
Concept | 2021 Q2 | 2020 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$2.010M | -$1.651M |
YoY Change | -27.7% | -45.83% |
Depreciation, Depletion And Amortization | $140.0K | $140.0K |
YoY Change | 0.0% | -33.33% |
Cash From Operating Activities | $11.83M | -$1.453M |
YoY Change | -694.47% | -61.73% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $73.00K | $68.00K |
YoY Change | -830.0% | 1.49% |
Acquisitions | $5.343M | |
YoY Change | ||
Other Investing Activities | -$5.340M | $0.00 |
YoY Change | -100.0% | |
Cash From Investing Activities | -$5.416M | -$68.00K |
YoY Change | 54060.0% | -58.28% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | $9.878M | |
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 9.889M | -2.000K |
YoY Change | 297.15% | -97.85% |
NET CHANGE | ||
Cash From Operating Activities | 11.83M | -1.453M |
Cash From Investing Activities | -5.416M | -68.00K |
Cash From Financing Activities | 9.889M | -2.000K |
Net Change In Cash | 16.37M | -1.514M |
YoY Change | 3240.2% | -62.33% |
FREE CASH FLOW | ||
Cash From Operating Activities | $11.83M | -$1.453M |
Capital Expenditures | $73.00K | $68.00K |
Free Cash Flow | $11.76M | -$1.521M |
YoY Change | -693.79% | -60.64% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2021Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
9878000 | |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
17000 | |
CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
366000 | |
CY2021Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1249000 | |
CY2021Q1 | us-gaap |
Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
|
166000 | |
CY2021Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
938000 | |
CY2021Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1409000 | |
CY2021Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
8681000 | |
CY2021Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
312000 | |
CY2021Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
1248000 | |
CY2021Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
22000 | |
CY2021Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-58954000 | |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2633000 | |
CY2021Q2 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
6000 | |
CY2021Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
38000 | |
CY2021Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
244000 | |
CY2021Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
250000 | |
CY2021Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
2185000 | |
CY2021Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1345000 | |
CY2021Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
12747000 | |
CY2021Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
2274000 | |
CY2021Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
816000 | |
CY2021Q2 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
10653000 | |
CY2021Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
95000 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | |
CY2021Q2 | us-gaap |
Liabilities
Liabilities
|
23910000 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
84419000 | |
CY2021Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q2 | us-gaap |
Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
|
81000 | |
CY2021Q1 | us-gaap |
Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
|
81000 | |
CY2021Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
289000 | |
CY2021Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
282000 | |
CY2021Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
22000 | |
CY2021Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q1 | us-gaap |
Liabilities
Liabilities
|
10603000 | |
CY2021Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | |
CY2021Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
15522809 | |
CY2021Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
165000 | |
CY2021Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
148000 | |
CY2021Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
15522809 | |
CY2021Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
74181000 | |
CY2021Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q1 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
CY2021Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
30000000 | |
CY2021Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
13899683 | |
CY2021Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
13899683 | |
CY2021Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
19000 | |
CY2021Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-19000 | |
CY2020Q1 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
5105000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17366000 | |
CY2021Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
7020000 | |
CY2020Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1649000 | |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1651000 | |
CY2020Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
5569000 | |
CY2021Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-56944000 | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
25649000 | |
CY2021Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
49559000 | |
CY2021Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
27969000 | |
CY2020Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.12 | |
CY2021Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-161000 | |
CY2021Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2002000 | |
CY2021Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8000 | |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2010000 | |
CY2020Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
9021000 | |
CY2020Q1 | us-gaap |
Gross Profit
GrossProfit
|
3916000 | |
CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
719000 | |
CY2021Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14346000 | |
CY2020Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-1644000 | |
CY2020Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
7000 | |
CY2020Q1 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
2000 | |
CY2021Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
11959000 | |
CY2020Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
1702000 | |
CY2021Q2 | us-gaap |
Gross Profit
GrossProfit
|
4939000 | |
CY2021Q2 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
205000 | |
CY2021Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
534000 | |
CY2021Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
2681000 | |
CY2021Q2 | us-gaap |
Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
|
38000 | |
CY2021Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-1972000 | |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
21149000 | |
CY2021Q2 | us-gaap |
Profit Loss
ProfitLoss
|
-2010000 | |
CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-1651000 | |
CY2021Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
366000 | |
CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
95000 | |
CY2020Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
42000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
900000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2292000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-943000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
35000 | |
CY2021Q2 | irix |
Increase Decrease In Prepaid Deferred Expense And Other Current Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
271000 | |
CY2020Q1 | irix |
Increase Decrease In Prepaid Deferred Expense And Other Current Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherCurrentAssets
|
290000 | |
CY2021Q2 | irix |
Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
|
-200000 | |
CY2020Q1 | irix |
Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
|
-302000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-53000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-11000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
539000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1091000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-91000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-681000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
458000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-28000 | |
CY2021Q2 | irix |
Increase Decrease In Accrued Warranty Liabilities
IncreaseDecreaseInAccruedWarrantyLiabilities
|
-42000 | |
CY2020Q1 | irix |
Increase Decrease In Accrued Warranty Liabilities
IncreaseDecreaseInAccruedWarrantyLiabilities
|
-140000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
11238000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-108000 | |
CY2021Q2 | irix |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-251000 | |
CY2020Q1 | irix |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-343000 | |
CY2021Q2 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
1458000 | |
CY2020Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
29000 | |
CY2021Q2 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
11830000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1453000 | |
CY2021Q2 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
73000 | |
CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
68000 | |
CY2021Q2 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
5343000 | |
CY2021Q2 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-5416000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-68000 | |
CY2021Q2 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9878000 | |
CY2021Q2 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
17000 | |
CY2021Q2 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
6000 | |
CY2020Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
2000 | |
CY2021Q2 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
9889000 | |
CY2020Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2000 | |
CY2021Q2 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
64000 | |
CY2020Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
9000 | |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
16367000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-1514000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11626000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
12653000 | |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
27993000 | |
CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
11139000 | |
CY2021Q2 | irix |
Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
|
27000 | |
CY2020Q1 | irix |
Transfer Of Inventory To Property And Equipment
TransferOfInventoryToPropertyAndEquipment
|
48000 | |
CY2021Q2 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on our operating results.</p> | |
CY2021Q2 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our cash and cash equivalents are deposited in demand and money market accounts. Deposits held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and therefore, bear minimal risk.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We market our products to distributors and end-users throughout the world. Sales to international distributors are generally made on open credit terms and letters of credit. Management performs ongoing credit evaluations of our customers and maintains an allowance for potential credit losses. Historically, we have not experienced any significant losses related to individual customers or a group of customers in any particular geographic area. For the three months ended April 3, 2021, no single customer accounted for more than 10% of total revenues. For the three months ended March 28, 2020, one customer accounted for more than 10% of total revenues, representing 13%. As of April 3, 2021, two customers accounted for over 10% of our accounts receivable, representing 13% and 12%, respectively. As of January 2, 2021, one customer accounted for more than 10% of our accounts receivable, representing 13%.  </p> | |
CY2021Q2 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Reclassifications.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain reclassifications have been made to the prior year financial statements included in these condensed consolidated financial statements to conform to the current year presentation. The reclassifications had no impact on previously reported total assets, total liabilities and net loss or accumulated deficit.</p> | |
CY2021Q2 | irix |
Service Contract Warranty Period
ServiceContractWarrantyPeriod
|
P1Y | |
CY2021Q2 | irix |
Service Contract Threshold Period To Determine Nature Of Sale
ServiceContractThresholdPeriodToDetermineNatureOfSale
|
P60D | |
CY2021Q2 | irix |
Refundable Arrangement Fee
RefundableArrangementFee
|
2000000 | |
CY2021Q2 | irix |
Arrangement Expiration Period
ArrangementExpirationPeriod
|
P9M | |
CY2021Q2 | irix |
Fair Value Of Distribution Right
FairValueOfDistributionRight
|
14800000 | |
CY2021Q2 | irix |
Arrangement Fee
ArrangementFee
|
3500000 | |
CY2021Q2 | irix |
Customer Deposit
CustomerDeposit
|
1500000 | |
CY2021Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
1227000 | |
CY2019Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
1810000 | |
CY2021Q2 | irix |
Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
|
11665000 | |
CY2020Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
535000 | |
CY2020Q1 | irix |
Contract With Customer Liability Deductions From Reserves
ContractWithCustomerLiabilityDeductionsFromReserves
|
6000 | |
CY2021Q2 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
12465000 | |
CY2020Q1 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
320000 | |
CY2020Q1 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
1382000 | |
CY2021Q2 | us-gaap |
Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
|
400000 | |
CY2020Q1 | us-gaap |
Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
|
400000 | |
CY2021Q2 | irix |
Noncurrent Portion Of Deferred Revenue Pertains To Exclusivity Fee Deferred Revenue
NoncurrentPortionOfDeferredRevenuePertainsToExclusivityFeeDeferredRevenue
|
10300000 | |
CY2021Q2 | irix |
Current Portion Of Deferred Revenue Pertains To Exclusivity Fee Deferred Revenue
CurrentPortionOfDeferredRevenuePertainsToExclusivityFeeDeferredRevenue
|
900000 | |
CY2021Q2 | irix |
Products Warranty Period
ProductsWarrantyPeriod
|
P2Y | |
CY2021Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
247000 | |
CY2019Q4 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
536000 | |
CY2021Q2 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
19000 | |
CY2020Q1 | us-gaap |
Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
|
31000 | |
CY2021Q2 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
21000 | |
CY2020Q1 | us-gaap |
Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
|
78000 | |
CY2021Q2 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
-40000 | |
CY2020Q1 | us-gaap |
Standard Product Warranty Accrual Preexisting Increase Decrease
StandardProductWarrantyAccrualPreexistingIncreaseDecrease
|
-93000 | |
CY2020Q1 | us-gaap |
Standard Product Warranty Accrual
StandardProductWarrantyAccrual
|
396000 | |
CY2021Q1 | irix |
Sale Of Equity Interest
SaleOfEquityInterest
|
10000000 | |
CY2021Q1 | irix |
Grant Of Exclusive Distribution Rights
GrantOfExclusiveDistributionRights
|
14800000 | |
CY2021Q1 | irix |
Purchase Of Tangible And Intangible Assets
PurchaseOfTangibleAndIntangibleAssets
|
-5343000 | |
CY2021Q1 | irix |
Net Proceeds
NetProceeds
|
19457000 | |
CY2021Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
3827000 | |
CY2021Q1 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
2236000 | |
CY2021Q1 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
548000 | |
CY2021Q1 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
2930000 | |
CY2021Q1 | us-gaap |
Goodwill
Goodwill
|
400000 | |
CY2021Q2 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
0 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
2540000 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
191000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
240000 | |
CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
50000 | |
CY2021Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
172000 | |
CY2021Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
19000 | |
CY2020Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
4000 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
144000 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
192000 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
192000 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
192000 | |
CY2021Q2 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
180000 | |
CY2021Q2 | irix |
Finite Lived Intangible Asset Amortization Expense After Year Four
FiniteLivedIntangibleAssetAmortizationExpenseAfterYearFour
|
449000 | |
CY2021Q2 | irix |
Finite Lived Intangible Asset Future Amortization Expense Total
FiniteLivedIntangibleAssetFutureAmortizationExpenseTotal
|
1349000 | |
CY2021Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
300000 | |
CY2020Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
300000 | |
CY2021Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.054 | |
CY2021Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y1M6D | |
CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
1131000 | |
CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
302000 | |
CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
3000 | |
CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
1486000 | |
CY2021Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
46000 | |
CY2021Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1440000 | |
CY2021Q2 | us-gaap |
Purchase Obligation
PurchaseObligation
|
13900000 | |
CY2021Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
366000 | |
CY2021Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
1600000 | |
CY2021Q2 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P2Y7D | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1649540 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
16000 | |
CY2021Q2 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
3082 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
99061 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1563397 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.67 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
4.90 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
5.29 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
4.54 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.68 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
4538000 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0074 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0046 | |
CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y5M12D | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P4Y6M18D | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
0.72 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
|
0.57 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
1353572 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
447476 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
4.78 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
7.11 | |
CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y9M25D | |
CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P5Y7M9D | |
CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P3Y6M25D | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
3875000 | |
CY2021Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
658000 | |
CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
6000 | |
CY2020Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | |
CY2021Q1 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
1200000 | |
CY2021Q2 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 |